929621-33-0

Basic information

• Product Name: 4-bromo-2-chloro-6-fluoro-Benzaldehyde
• Synonyms: 4-bromo-2-chloro-6-fluoro-Benzaldehyde
• CAS NO: 929621-33-0
• Molecular Formula: C₇H₃BrClFO
• Molecular Weight: 237.4535232
• Mol File: 929621-33-0.mol

Chemical Properties

• Boiling Point: 262.6±40.0 °C(Predicted)
• Appearance: /
• Density: 1.779±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 4-bromo-2-chloro-6-fluoro-Benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-chloro-6-fluoro-Benzaldehyde(929621-33-0)
• EPA Substance Registry System: 4-bromo-2-chloro-6-fluoro-Benzaldehyde(929621-33-0)

Safety Data

• Hazardous Substances Data: 929621-33-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-bromo-2-chloro-6-fluoro-Benzaldehyde serves as a key starting material for the synthesis of various pharmaceuticals. Its distinct chemical structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4-bromo-2-chloro-6-fluoro-Benzaldehyde is utilized as a precursor in the production of pesticides and other agrochemicals. Its unique characteristics contribute to the creation of effective and targeted solutions for agricultural applications.

Upstream product

• 33863-76-2 1-bromo-3-chloro-5-fluorobenzene 
• 68-12-2 N,N-dimethyl-formamide 
• 1321613-02-8 methyl 4-bromo-2-chloro-6-fluorobenzoate 

Downstream Products

• 929621-34-1 5-bromo-1-chloro-2-difluoromethyl-3-fluorobenzene 

Relevant articles and documents

New compound used as rearranged during transfection kinase inhibitor

The present invention relates to a compound, a pharmaceutical composition containing the compound, a preparation method of the compounds, and application of the same as a rearranged during transfection (RET) kinase inhibitor. The compound is a compound shown as formula (I), or a pharmaceutically acceptable salt, a prodrug, a solvent compound, a polymorph, an isomer and a stable isotope derivativethereof. The present invention also relates to the application of the compounds to treatment or prevention of RET kinase mediated related diseases like tumors and a method of using the compounds for the treatment of the diseases.

ATAZANAVIR (ATV) ANALOGUES FOR TREATING HIV INFECTIONS

The invention provides a compound of Formula I: or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, the compound of formula (I) for use in therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I. Preferred compounds are N-[(2S) -1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino) -3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(phenyl) methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate atazanavir (ATV) analogues substituted by several heterocycles, such as e.g. pyrazole (Rl); e.g. oxetane (substituent of X2); e.g. pyridine or pyrimidine (X1); e.g. piperazine or 3,8-diazabicyclo[3.2.1]octan (X2).

BIPHENYL SULFIDE COMPOUNDS AND INSECTICIDES AND MITICIDES

Compounds exerting high activities against various destructive insects and/or mites in agricultural and horticultural field, particularly excellent miticidal activity against Panonychus citri which is a weighty pest to citrus fruits, namely, biphenyl sulf